Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-11 5:15 pm Purchase |
2025-04-04 | 13G | Viridian Therapeutics, Inc. VRDN |
Commodore Capital LP | 4,300,000 5.300% |
2,375,926![]() (+123.48%) |
Filing History |
2025-02-14 6:05 pm Unchanged |
2024-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Venrock Healthcare Capital Partners III L.P. | 3,575,309 4.500% |
0 (Unchanged) |
Filing History |
2024-11-14 5:53 pm Sale |
2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
Venrock Opportunities Fund L.P. | 1,882,615 2.900% |
-941,306![]() (-33.33%) |
Filing History |
2024-11-14 5:52 pm Sale |
2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
Venrock Healthcare Capital Partners III L.P. | 3,575,309 5.500% |
-1,980,259![]() (-35.64%) |
Filing History |
2024-11-14 4:50 pm Sale |
2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
PERCEPTIVE ADVISORS LLC | 2,812,665 3.800% |
-1,209,401![]() (-30.07%) |
Filing History |
2024-11-14 4:33 pm Sale |
2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
Paradigm BioCapital Advisors LP | 3,509,253 4.600% |
-1,795,060![]() (-33.84%) |
Filing History |
2024-10-18 12:33 pm Sale |
2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
STATE STREET CORP STT |
2,379,774 3.200% |
-328,609![]() (-12.13%) |
Filing History |
2024-09-17 9:00 pm Purchase |
2024-09-13 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 15,556,685 17.950% |
1,600,000![]() (+11.46%) |
Filing History |
2024-04-01 6:38 pm Unchanged |
2024-03-28 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 13,956,685 18.640% |
0 (Unchanged) |
Filing History |
2024-02-14 8:28 pm Purchase |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Venrock Healthcare Capital Partners III L.P. | 5,555,568 9.990% |
1,324,947![]() (+31.32%) |
Filing History |
2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Paradigm BioCapital Advisors LP | 5,304,313 9.990% |
2,993,615![]() (+129.55%) |
Filing History |
2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Commodore Capital LP | 1,924,074 3.700% |
552,735![]() (+40.31%) |
Filing History |
2024-02-14 09:22 am Sale |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,302,094![]() (Position Closed) |
Filing History |
2024-02-14 09:01 am Purchase |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Deep Track Capital, LP | 5,378,997 9.900% |
2,066,023![]() (+62.36%) |
Filing History |
2024-02-13 5:17 pm Purchase |
2023-12-29 | 13G | Viridian Therapeutics, Inc. VRDN |
The Vanguard Group | 3,000,948 5.710% |
885,954![]() (+41.89%) |
Filing History |
2024-01-29 4:53 pm Purchase |
2024-01-18 | 13G | Viridian Therapeutics, Inc. VRDN |
PERCEPTIVE ADVISORS LLC | 4,022,066 6.700% |
4,022,066![]() (New Position) |
Filing History |
2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
BLACKROCK INC BLK |
3,426,450 6.500% |
664,894![]() (+24.08%) |
Filing History |
2024-01-24 5:12 pm Purchase |
2024-01-22 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 13,956,685 19.430% |
1,192,292![]() (+9.34%) |
Filing History |
2024-01-24 08:13 am Purchase |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
STATE STREET CORP STT |
2,708,383 5.150% |
2,708,383![]() (New Position) |
Filing History |
2024-01-10 08:53 am Purchase |
2024-01-09 | 13G | Viridian Therapeutics, Inc. VRDN |
FMR CORP | 7,625,542 14.501% |
7,625,542![]() (New Position) |
Filing History |